Take CTRP Profits!
Plus, MON Misses
PLAY: Sell your CTRP February 75 Calls (QCT BO) at market, good for the day.
Dear Bottarelli Research Member,
This morning, Monsanto (MON – NYSE) reported a $19 million loss (-$0.03 per share) in the three months ended November 30th compared to a profit of $556 million a one year ago. Sales of $1.7 billion came in down -35% from $2.6 billion a year earlier. And since Thomson Reuters analysts estimated sales of nearly $2 billion, this is certainly a miss (Monsanto’s third straight earnings disappointment).
As you know, we sold the combination of MON January 85 Calls (MON AQ) and MON January 80 Puts (MON MP) yesterday. For those of you who decided to sell half, let’s see how MON reacts. If the shares indicate that a bounce could occur, we’ll ditch the puts. But if shares indicate that they’ll continue falling, we’ll ditch the calls. We’ll know more as the day progresses.
In the meantime, let’s go ahead and lock in profits on Ctrip.com International (CTRP – NASDAQ). The CTRP February 75 Calls (QCT BO) we entered yesterday for $5.20 hit a high late yesterday afternoon of $6.20, good for a quick 20% gainer. In a market like this, I want to protect our profits. So in that spirit, let’s lock in these gains now!
PLAY: Sell your CTRP February 75 Calls (QCT BO) at market, good for the day.
As always, I’ll be out with further updates as the day progresses. Until then…
Lock and load!
Sincerely,
© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.